Arena Pharma (ARNA) Tops Q4 EPS by 24c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. SBUX
3. LEVI
4. HUM
5. NVDA
6. CMG
7. ALHC
8. STZ
9. AAPL
10. SPY

Go back to Arena Pharma (ARNA) Tops Q4 EPS by 24c

Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results

March 14, 2017 4:01 PM EDT

SAN DIEGO, March 14, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today provided a corporate update and reported financial results for the fourth quarter and full-year ended December 31, 2016.

"We are very pleased with our progress in 2016 as we have positioned the Company to deliver results on multiple Phase 2 programs in 2017.  In the last nine months since the arrival of the new management team, we prioritized... More